Research programme: IMM ALL 03 - Immuneering
Alternative Names: AO.03 inhibitors; IMM-ALL-03Latest Information Update: 20 Apr 2022
At a glance
- Originator Immuneering
- Class Antidementias; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Alzheimer's disease